Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
3
×
alexion pharmaceuticals
alnylam pharmaceutials
arrowhead pharmaceuticals
atrial fibrillation
biopharma
boehringer ingelheim
boston scientific
clinical trial
clinical trials
cryterion medical
dicerna pharmaceuticals
duchenne
eli lilly
europe blog main
europe top stories
fda
food and drug administration
hepatitis b
indiana blog main
indiana top stories
investing
johnson & johnson
licensing
m&a
medical devices
mergers & acquisitions
millipede
muscular dystrophy
neurodegenerative diseases
primary hyperoxaluria
rna interference
roche
What
deal
3
×
rna
abandoning
acquire
adding
ago
approval
atrial
baggage
betting
billion
biopharma
boston
business
companies
continues
cryterion
cuts
development
device
dicerna
duchenne
fda
fibrillation
free
gene
gets
heart
historic
interference
long
management
medicine
medicines
pharma
puts
recently
rhythm
rnai
roche
Language
unset
Current search:
deal
×
boston
×
" national top stories "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
